Advanced Magnetics' Feridex
This article was originally published in The Gray Sheet
Executive Summary
Firm licenses marketing rights to its liver cancer magnetic resonance imaging agent to Sterling's Sanofi Winthrop. Under the agreement announced Sept. 28, Sterling will make payments of up to $7.75 mil. in exchange for marketing rights in the U.S., Canada, Mexico and Australia. Advanced Magnetics will also receive royalties on sales and payments for supplying the product. Advanced Magnetics says it plans to file a new drug application for the contrast agent by March 1994.